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Abstract
Background:  Pain  is  the  primary  complaint  and  the  main  reason  for  prolonged  recovery  after
laparoscopic  cholecystectomy.  The  authors  hypothesized  that  patients  undergoing  laparoscopic
cholecystectomy  will  have  less  pain  four  hours  after  surgery  when  receiving  maintenance  of
anesthesia  with  propofol  when  compared  to  isoﬂurane,  desﬂurane,  or  sevoﬂurane.
Methods:  In  this  prospective,  randomized  trial,  80  patients  scheduled  for  laparoscopic  cholecys-
tectomy  were  assigned  to  propofol,  isoﬂurane,  desﬂurane,  or  sevoﬂurane  for  the  maintenance
of anesthesia.  Our  primary  outcome  was  pain  measured  on  the  numeric  analog  scale  four  hours
after surgery.  We  also  recorded  intraoperative  use  of  opioids  as  well  as  analgesic  consumption
during the  ﬁrst  24  h  after  surgery.
Results:  There  was  no  statistically  signiﬁcant  difference  in  pain  scores  four  hours  after  surgery
(p =  0.72).  There  were  also  no  statistically  signiﬁcant  differences  in  pain  scores  between  treat-
ment groups  during  the  24  h  after  surgery  (p  =  0.45).  Intraoperative  use  of  fentanyl  and  morphine
did not  vary  signiﬁcantly  among  the  groups  (p  =  0.21  and  0.24,  respectively).  There  were  no  dif-
ferences in  total  morphine  and  hydrocodone/APAP  use  during  the  ﬁrst  24  h  (p  =  0.61  and  0.53,
respectively).
Conclusion:  Patients  receiving  maintenance  of  general  anesthesia  with  propofol  do  not  have
less pain  after  laparoscopic  cholecystectomy  when  compared  to  isoﬂurane,  desﬂurane,  or
sevoﬂurane.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.   
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revious  studies  investigating  postoperative  pain  after
aparoscopic  cholecystectomy  reported  large  amounts  of
nter-individual  variation.2 Pain  after  laparoscopic  chole-
ystectomy  has  three  components:  incisional  pain,  visceral
ain,  and  referred  shoulder  pain.2 Over  the  past  20  years,
everal  studies  have  examined  this  issue  using  a  multimodal
pproach  to  postoperative  pain  management  after  laparo-
copic  cholecystectomy.3--8
The  inhalational  anesthetics  isoﬂurane,  desﬂurane  and
evoﬂurane  are  commonly  used  to  provide  maintenance
f  general  anesthesia  during  surgery.  Certain  inhalational
gents  reportedly  increase  sensitivity  to  pain  at  lower
oncentrations  as  present  during  emergence,  but  relieve
ain  at  higher  concentrations.9 The  differential  effects  of
nhalational  agents  on  nociceptive  pathways  may  inﬂuence
ostoperative  pain  development.  Speciﬁcally,  investigators
ave  shown  that  isoﬂurane  hyperalgesia  may  be  modulated
y  the  nicotinic  receptor.10
Clinical  studies  examining  propofol  versus  inhalational
gents  for  the  maintenance  of  general  anesthesia  reveal
otential  beneﬁts  to  propofol  administration  which  include:
mprovements  in  well-being,  decreased  postoperative  pain
cores,  and  decreased  incidence  of  postoperative  nausea
nd  vomiting  (PONV).11--14 However,  not  all  of  these  studies
ere  designed  or  powered  to  look  speciﬁcally  at  postopera-
ive  pain.  A  study  by  Fassoulaki15 did  not  show  any  difference
n  postoperative  pain  scores  after  abdominal  hysterectomy
r  myomectomy  when  comparing  propofol,  desﬂurane,  and
evoﬂurane  for  maintenance  of  anesthesia.  The  conﬂicting
ndings  with  regard  to  the  potential  analgesic  beneﬁt  of
ropofol  use  for  maintenance  of  anesthesia  have  resulted
n  a  number  of  varying  opinions  within  the  anesthesiology
iterature.16--18
To  our  knowledge,  no  study  investigating  differences  in
ostoperative  pain  following  laparoscopic  cholecystectomy
as  been  reported  in  the  literature  comparing  mainte-
ance  of  anesthesia  with  propofol,  isoﬂurane,  desﬂurane,
r  sevoﬂurane.  The  authors  felt  it  would  be  important  to
ompare  propofol  to  all  three  of  the  commonly  used  inhala-
ional  agents  in  this  study,  as  different  results  have  been
ound  when  comparing  propofol  to  each  of  the  separate
gents.11--15 Our  hypothesis  was  that  maintenance  of  anes-
hesia  with  propofol  will  result  in  less  pain  four  hours  after
aparoscopic  cholecystectomy  when  compared  to  isoﬂurane,
esﬂurane,  or  sevoﬂurane.
atients, materials and methods
atient  recruitment
he  study  protocol  was  approved  by  the  Baylor  College  of
edicine  IRB  in  August  2009  and  registered  at  ClinicalTri-
ls.gov  (NCT00983918,  September  2009).  Informed,  written
onsent  was  obtained  from  80  inpatients  between  the  ages
f  18  and  64  classiﬁed  as  American  Society  of  Anesthesiolo-
ists  (ASA)  physical  status  I,  II,  or  III,  scheduled  to  undergo
aparoscopic  cholecystectomy  at  Ben  Taub  General  Hospi-
al  in  Houston,  Texas.  Patients  were  excluded  if  any  of  the
ollowing  applied:  scheduled  for  outpatient  surgery,  sched-
led  for  open  cholecystectomy,  renal  dysfunction  (Cr  >  1.2),
llergy  to  any  of  the  study  medications,  chronic  opioid  use  at
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ome,  or  inability  to  properly  describe  postoperative  pain  to
nvestigators  (e.g.,  language  barrier,  neuropsychiatric  dis-
rder).  Patients  were  enrolled  by  study  investigators  from
eptember  23,  2009  to  June  10,  2010.  Study  recruitment
as  placed  on  hold  from  December  23,  2009  to  March  9,
010  due  to  a  local  shortage  of  propofol.
andomization
atients  were  assigned  to  one  of  four  study  groups  using
 computer  randomization  scheme  generated  by  a  depart-
ent  administrator  using  the  website  Randomization.com
http://www.randomization.com).  Patients  had  an  equal
5%  chance  of  assignment  to  any  of  the  groups.  Group  assign-
ents  were  placed  inside  numbered  opaque  envelopes  as
ollows:  Group  P  --  maintenance  of  anesthesia  with  propofol
nfusion;  Group  I  --  maintenance  of  anesthesia  with  isoﬂu-
ane;  Group  D  --  maintenance  of  anesthesia  with  desﬂurane;
nd  Group  S  --  maintenance  of  anesthesia  with  sevoﬂurane.
pon  enrollment,  all  subjects  were  familiarized  with  the
umerical  analog  scale  (NAS)  and  the  postoperative  pain
outine.  It  was  explained  that  a score  of  ‘‘0’’  represented
o  pain  and  a  score  of  ‘‘10’’  represented  the  worst  pain
maginable.  Patients,  surgeons  and  nurses  assessing  pain
cores  were  blinded  with  regard  to  group  assignment  and
nesthetic  agent.  The  members  of  the  anesthesia  team  per-
orming  the  general  anesthetic  were  not  blinded.
nesthetic  technique
fter  placement  of  a  peripheral  venous  catheter,  a  lac-
ated  ringer’s  infusion  was  started.  A  preoperative  pain
core  at  rest  was  recorded  at  this  time.  Standard  moni-
oring  and  Bispectral  index  (BIS)  (Aspect  Medical  Systems,
orwood,  MA)  monitoring  were  applied  for  all  groups.  Mida-
olam  1--2  mg  IV  was  given  for  anxiolysis  as  needed.  After
re-oxygenation  with  100%  oxygen,  anesthesia  was  induced
ith  fentanyl  2  mcg/kg,  lidocaine  1  mg/kg,  and  propofol
.5  mg/kg.  Tracheal  intubation  was  facilitated  with  either
uccinylcholine  1--2  mg/kg  or  rocuronium  0.6  mg/kg.
Maintenance  of  anesthesia  was  provided  as  follows:
roup  P  --  propofol  infusion,  Group  I --  isoﬂurane,  Group
 --  desﬂurane,  and  Group  S  --  sevoﬂurane.  The  amount  of
nesthetic  for  all  groups  was  titrated  to  maintain  a  BIS  value
etween  30  and  50  during  the  procedure.  Muscle  relaxation
as  maintained  with  rocuronium.  Additional  administration
f  fentanyl  50--100  mcg  was  given  at  the  discretion  of  the
nesthesia  team  during  the  procedure.  All  patients  received
ndansetron  4  mg  IV  and  ketorolac  30  mg  IV  after  removal  of
he  gallbladder.  Neuromuscular  blockade  was  antagonized
ith  neostigmine  and  glycopyrrolate  at  the  end  of  surgery.
he  anesthesia  team  was  instructed  to  give  morphine  as
eeded  at  the  end  of  the  procedure  to  assist  with  emer-
ence.
All  patients  received  a  standard  laparoscopic  cholecys-
ectomy  with  pneumoperitoneum  pressures  maintained  at
5  mm  Hg  throughout.  A  total  of  10  mL  of  bupivacaine  0.25%
as  injected  subcutaneously  at  the  trocar  insertion  sites
fter  wound  closure  by  the  surgical  team  as  follows:  3  mL
or  each  of  the  10  mm  trocar  incisions,  and  2  mL  for  each  of
he  5  mm  trocar  incisions.
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Postoperative  care  and  pain  assessment
Time  of  arrival  to  the  post-anesthesia  care  unit  (PACU)
became  Time  0  for  our  pain  assessments.  Pain  at  rest
was  recorded  for  each  patient  using  the  NAS  (0--10)  at
Time  0,  and  at  1,  2,  4,  8,  12,  and  24  h  after  the  surgery
was  completed.  All  patients  were  placed  on  a  postop-
erative  analgesic  regimen  which  included  hydrocodone
5  mg/acetaminophen  500  mg  tablets,  2  tablets  given  for  mild
pain  (NAS  3--5)  every  6  h  with  a  maximum  of  6  tablets  in  a
24  h  period,  and  morphine  4  mg  IV,  given  every  3  h  for  severe
pain  (NAS  6--10).  Pain  scores  were  recorded  by  the  PACU  and
ﬂoor  nurses  taking  care  of  the  patient  without  knowledge
of  patient  group  assignment.  In  addition,  analgesic  use  and
PONV  events  during  the  ﬁrst  24  h  were  recorded.
StatisticsThe  primary  outcome  was  postoperative  pain  scores  on  the
NAS  from  0  to  10  four  hours  after  surgery.  The  secondary
outcome  was  pain  scores  during  the  ﬁrst  24  h  after  surgery.
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 study  by  Gupta19 reported  that  pain  after  laparoscopic
holecystectomy  had  a  standard  deviation  of  ±2  on  the
isual  analog  scale.  Assuming  a  common  standard  deviation
f  2.5  units  since  we  used  a  numerical  analog  scale,  a  total  of
8  patients  per  group  would  be  required  to  detect  a  3  unit
ifference  between  two  groups  with  80%  power  assuming
lpha  =  0.01.  An  alpha  =  0.01  level  was  assumed  to  maintain
n  overall  Type  I  error  rate  of  0.05  for  multiple  comparisons.
o  account  for  any  patient  dropouts  or  missing  patient  data,
e  planned  to  enroll  20  patients  per  study  group  for  a  total
f  80  patients.
Patient  demographics,  surgery  characteristics,  analgesic
se,  and  pain  scores  were  compared  across  treatment
roups.  A  one-way  ANOVA  model  was  used  to  compare
ean  postoperative  pain  scores  at  four  hours  after  surgery
cross  treatment  groups  as  well  as  continuously  measured
aseline  and  surgical  covariates.  Categorical  variables  were
ompared  using  Fisher’s  exact  test.  The  overall  effect  of
reatment  groups  during  the  ﬁrst  24  h  after  surgery  was
ompared  using  a  general  linear  mixed  model  assuming
n  unstructured  covariance  matrix  of  correlated  errors.
he  model  included  ﬁxed  effects  for  treatment  group,
ligibility (n=97)
zed (n=80)
Propofol (n=20) Desflurane (n=20)
Lost to follow-up (n=0)Lost to follow-up (n=0)
Analysed (n=18)
® Excluded from analysis–
open cholecystectomy (n=2)
Analysed (n=20)
® Excluded from analysis–
open cholecystectomy (n=0)
Excluded (n=17)
® Not meeting inclusion criteria (n=8)
® Declined to participate (n=9)
 ﬂow  diagram.
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Table  1  Patient  demographics  and  surgical  characteristics.
PROP  ISO  DES  SEVO
(n =  18)  (n  =  18)  (n  =  20)  (n  =  18)
Age  29(7)  34(12)  33(12)  34(14)
Weight (kg)  76(22)  80(16)  77(27)  74(16)
Height (in.)  62(2)  63(3)  63(3)  63(4)
Female 18(100)  16(89)  14(70)  15(83)
ASA class
1  10(55)  5(28)  5(25)  7(39)
2 7(39)  13(72)  14(70)  10(55)
3 1(6) 0(0) 1(5)  1(6)
Diagnosis
AC 11(61) 10(55) 12(60) 9(50)
BC  4(22)  5(28)  3(15)  8(44)
GP 3(17)  3(17)  5(25)  1(6)
Surgery time  (min)  93(16)  102(45)  88(23)  86(28)
Anesthesia time  (min)  148(19)  155(47)  142(24)  142(33)
Estimated blood  loss  (mL)  39(25)  47(54)  42(34)  37(28)
Nausea
No 15(83) 13(72) 16(80)  16(89)
Yes 3(17) 5(28)  4(20)  2(11)
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ime,  and  group--time  interaction  term.  Treatment  and  time
ere  modeled  as  categorical  variables.  The  model  was
lso  adjusted  for  covariates  including  age,  weight,  height,
ex,  ASA  classiﬁcation,  diagnosis,  intraoperative  morphine,
ntraoperative  fentanyl,  surgery  time,  anesthesia  time,  and
stimated  blood  loss.  Statistical  signiﬁcance  was  assessed
t  ˛  =  0.05.  All  analyses  were  performed  using  SAS  9.2  (SAS
nstitute  Inc.,  Cary,  NC).
esults
he  CONSORT  patient  ﬂow  diagram  is  shown  in  Fig.  1. A  total
f  80  patients  were  prospectively  enrolled  in  the  study.  Six
atients  were  subsequently  excluded  from  the  ﬁnal  analyses
ecause  they  met  one  of  the  exclusion  criteria  (conver-
ion  of  laparoscopic  to  open  procedure).  The  remaining
4  patients  included  in  the  ﬁnal  analyses  were  distributed
s  follows:  20  patients  in  the  desﬂurane  group,  and  18
atients  each  in  the  propofol,  isoﬂurane,  and  sevoﬂurane
roups.
Our  overall  patient  population  was  85%  female.  The  pop-
lation  was  85%  Latin  American,  6.25%  Caucasian,  6.25%
frican  American,  and  2.5%  Asian.  The  preoperative  diag-
oses  were  distributed  as  follows:  acute  cholecystitis  in  56%,
iliary  colic  in  28%,  and  gallstone  pancreatitis  in  16%  of  the
atients.
A  summary  of  demographic  and  surgical  data  is  shown
n  Table  1.  Table  2  summarizes  the  analgesic  consumption
ata.  We  did  not  ﬁnd  a  statistically  signiﬁcant  differ-
nce  in  the  intraoperative  use  of  fentanyl  and  morphine
etween  the  groups  (p  =  0.21  and  0.24,  respectively).  Addi-
ionally,  there  were  no  differences  in  total  morphine  and
ydrocodone/APAP  use  during  the  ﬁrst  24  h  (p  =  0.61  and
.53,  respectively).
l
p
sles are presented as n(%).
Fig.  2  shows  pain  scores  for  the  ﬁrst  24  h  for  all  groups.
here  was  no  statistically  signiﬁcant  difference  in  pain
cores  four  hours  after  surgery  (p  =  0.72).  Differences  in
ain  scores  between  treatment  groups  did  not  depend  on
ime  (p  =  0.43),  and  the  interaction  term  was  removed  from
he  model.  There  were  no  statistically  signiﬁcant  differ-
nces  in  pain  scores  between  treatment  groups  (p  =  0.45).
ime  was  signiﬁcantly  associated  with  pain  score  (p  <  0.001).
ven  after  adjusting  for  preoperative  pain  scores,  treatment
roups  were  not  statistically  different  (p  =  0.42).  Patient  age
as  signiﬁcantly  associated  with  pain  score  (p  <  0.001).  On
verage,  pain  scores  decreased  by  0.7  units  for  every  10-year
ncrease  in  age.  Otherwise,  no  other  covariates  were  signiﬁ-
antly  associated  with  postoperative  pain  scores  (p  >=  0.16).
The  largest  differences  between  mean  pain  scores
ccurred  one  hour  after  arrival  to  PACU.  All  pairwise  com-
arisons  were  tested  for  signiﬁcant  differences  using  an
ndependent,  two-sample  t-test.  After  adjusting  for  multi-
le  comparisons  using  the  Bonferroni  correction,  only  the
ifference  between  propofol  and  desﬂurane  was  statistically
igniﬁcant  (p  =  0.04).  All  other  comparisons  were  not  signif-
cant  (p  >=  0.07)  assuming  an  overall  Type  1  error  rate  of
.05.
iscussion
he  results  of  this  study  do  not  support  the  hypothesis  that
atients  receiving  maintenance  of  anesthesia  with  propofol
ave  less  pain  four  hours  after  laparoscopic  cholecystectomy
hen  compared  to  isoﬂurane,  desﬂurane,  or  sevoﬂurane.
Our  ﬁndings  differ  from  recent  studies  that  reported
ower  pain  scores  after  surgery  in  patients  anesthetized  with
ropofol  when  compared  to  isoﬂurane  or  sevoﬂurane.11,12 A
tudy  by  Cheng11 showed  an  analgesic  beneﬁt  of  propofol
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Table  2  Analgesic  comparison.
PROP  ISO  DES  SEVO  p
(n =  18)  (n  =  18)  (n  =  20)  (n  =  18)
Preop  pain  score  (0--10)  1.3(2.4)  0.4(1.1)  1.7(2.1)  1.1(2.1)  0.28
Intraop fentanyl
>250  mcg  6(33)  11(61)  8(40)  5(28)
<250 mcg  12(67)  7(39)  12(60)  13(72)  0.21
Intraop morphine  (mg)  6.1(4.3)  5.1(4.1)  3.6(4.0)  6.1(4.8)  0.24
24 h  morphine  (mg)  16(8)  15(11)  12(7)  13(8)  0.61
Hydrocodone/APAP  (#)  1.9(1.8)  1.9(2.1)  2.2(1.6)  1.3(1.8)  0.53
Continuous variables are presented as mean(SD) and categorical variables are presented as n(%). p-values obtained by comparing summary
measures across treatment groups using one-way ANOVA for continuously measured variables and Fisher’s exact test for categorical
variables.
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when  compared  to  isoﬂurane,  but  only  two  pain  scores  were
recorded  after  the  ﬁrst  hour,  at  2  and  24  h  after  surgery.  The
study  by  Tan12 showed  patients  had  less  pain  with  propo-
fol  when  compared  to  sevoﬂurane,  but  only  looked  at  pain
scores  during  the  ﬁrst  four  hours  after  surgery.  In  contrast,
our  study  showed  no  signiﬁcant  difference  in  pain  scores
for  the  sevoﬂurane  and  propofol  groups  throughout  the  24  h
postoperative  period.
Advocates  of  utilizing  propofol  for  maintenance  of  anes-
thesia  often  refer  to  studies  linking  inhaled  anesthetics
and  pain  on  the  biochemical  level.  For  example,  Zhang9
and  Flood10 both  reported  on  the  hyperalgesic  qualities
of  isoﬂurane.  Recently,  isoﬂurane  and  desﬂurane  were
found  to  activate  transient  receptor  potential  (TRP)-A1  in
g
o
t errors  by  time  and  anesthetic  type.
 concentration-dependent  manner.20 TRP-A1  is  present  in
eripheral  nociceptors.  This  same  effect  was  not  observed
ith  halothane  or  sevoﬂurane,  suggesting  that  activation  of
RP-A1  may  play  a  role  in  the  development  of  hyperalgesia
y  the  irritant  volatile  anesthetics.20 Although  patients  in
ur  study  that  were  anesthetized  with  desﬂurane  were  found
o  have  more  pain  one  hour  after  surgery  when  compared  to
ropofol,  this  difference  was  not  found  to  be  statistically
igniﬁcant  at  any  of  the  other  measured  time  points  during
he  ﬁrst  24  h.Although  we  were  unable  to  show  that  propofol  has  anal-
esic  beneﬁts  when  compared  to  the  inhalational  agents,
ur  study  has  limitations.  This  study  was  powered  based  on
he  primary  outcome  of  postoperative  pain  scores  and  not  on
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nalgesic  consumption  over  the  ﬁrst  24  h.  Although  we  found
o  statistically  signiﬁcant  differences  in  the  use  of  fen-
anyl,  morphine,  or  hydrocodone/APAP  in  our  study  groups,
his  may  need  further  investigation  using  a  study  powered
or  that  speciﬁc  outcome.  Some  of  the  statistical  methods
sed  to  analyze  the  data  make  normality  assumptions,  but
he  NAS  is  inherently  non-normal.  However,  nonparamet-
ic  analysis  using  Kruskal--Wallis  and  Kolmogorov--Smirnov
ests  yielded  nearly  identical  results.  The  only  notable  dif-
erence  was  that  the  Bonferroni  adjusted  p-value  comparing
ropofol  and  desﬂurane  one  hour  after  surgery  was  no  longer
igniﬁcant  (p  =  0.12).
In  addition,  we  modeled  our  protocol  based  on  the  com-
on  postoperative  pain  management  of  patients  at  our
nstitution,  which  includes  a  multimodal  approach  with  local
nesthetics,  NSAIDS  and  opioids.  These  analgesic  agents
ffect  postoperative  pain  and  could  mask  any  differences
etween  propofol  and  the  inhalational  agents.  For  compari-
on  purposes,  patients  received  postoperative  PCA  morphine
n  the  study  by  Cheng11 which  showed  that  patients  anes-
hetized  with  propofol  had  less  pain  compared  to  isoﬂurane
fter  open  uterine  surgery.  Patients  undergoing  diagnostic
aparoscopic  gynecological  surgery  in  the  study  by  Tan12 had
ess  pain  after  propofol  when  compared  to  sevoﬂurane,  but
eceived  paracetamol,  diclofenac,  dexamethasone,  mor-
hine  and  oxycodone  as  part  of  their  multimodal  regimen.
We  chose  to  use  propofol  as  the  IV  induction  agent  for
ll  groups  in  this  study  since  this  is  common  practice  at
ur  institution.  Although  it  can  be  argued  that  an  inhalation
nduction  would  be  the  best  study  design  for  the  patients
eceiving  maintenance  of  anesthesia  with  isoﬂurane,  des-
urane,  or  sevoﬂurane,  the  risk  of  aspiration  in  this  patient
opulation  and  difﬁculties  with  inhalation  inductions  in
dult  patients  made  this  impractical.  Therefore,  we  cannot
isregard  any  potential  effects  on  pain  that  an  induction
ose  of  propofol  could  have  on  all  groups.
Another  potential  confounder  is  that  some  of  our  patients
eceived  succinylcholine  at  the  anesthesiologist’s  discre-
ion.  We  felt  it  was  important  to  allow  this  choice  as  many
atients  in  our  study  population  have  risk  factors  for  aspi-
ation  or  difﬁcult  ventilation  and  intubation,  and  as  such,
he  use  of  succinylcholine  may  be  preferred  over  rocuro-
ium  for  induction  and  intubation.  It  is  possible  that  some
f  our  patients  may  have  had  post  fasciculation  muscle  pain
aused  by  succinylcholine  which  could  have  affected  our
ostoperative  pain  assessments.
Many  previous  clinical  studies  on  pain  after  laparoscopic
holecystectomy  commonly  have  a  patient  population  with
 primary  diagnosis  of  biliary  colic  and  surgery  is  usually  per-
ormed  in  the  outpatient  setting.  A  majority  of  patients  in
ur  study  were  undergoing  operation  for  acute  cholecysti-
is.  This  subgroup  of  patients  may  have  more  pain  during
he  perioperative  period  when  compared  to  patients  with  a
rimary  diagnosis  of  biliary  colic  or  gallstone  pancreatitis.
his  increased  perioperative  pain  in  our  patient  population
ould  mask  any  potential  difference  between  the  mainte-
ance  agents.  However,  this  heterogeneous  population  is  a
ommon  patient  mix  at  many  community  hospitals.In  conclusion,  maintenance  of  general  anesthesia  with
ropofol  did  not  lead  to  decreased  pain  scores  four
ours  after  laparoscopic  cholecystectomy  when  com-
ared  to  isoﬂurane,  desﬂurane,  or  sevoﬂurane.  Further,
1J.  Ortiz  et  al.
ell-designed  studies  are  needed  to  ascertain  whether
ropofol  has  any  beneﬁcial  effect  on  postoperative  pain
hen  compared  to  the  inhalational  agents  after  other  sur-
ical  procedures  in  the  setting  of  multimodal  analgesia.
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